StemRIM Management

Management criteria checks 2/4

StemRIM's CEO is Masatsune Okajima, appointed in Mar 2019, has a tenure of 5.17 years. total yearly compensation is ¥177.56M, comprised of 16.9% salary and 83.1% bonuses, including company stock and options. directly owns 0.41% of the company’s shares, worth ¥120.98M. The average tenure of the management team and the board of directors is 2.9 years and 4.6 years respectively.

Key information

Masatsune Okajima

Chief executive officer

JP¥177.6m

Total compensation

CEO salary percentage16.9%
CEO tenure5.2yrs
CEO ownership0.4%
Management average tenure2.9yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

StemRIM's (TSE:4599) Earnings Seem To Be Promising

Mar 20
StemRIM's (TSE:4599) Earnings Seem To Be Promising

CEO Compensation Analysis

How has Masatsune Okajima's remuneration changed compared to StemRIM's earnings?
DateTotal CompensationSalaryCompany Earnings
Jan 31 2024n/an/a

JP¥179m

Oct 31 2023n/an/a

JP¥214m

Jul 31 2023JP¥178mJP¥30m

JP¥168m

Compensation vs Market: Masatsune's total compensation ($USD1.16M) is above average for companies of similar size in the JP market ($USD842.11K).

Compensation vs Earnings: Insufficient data to compare Masatsune's compensation with company performance.


CEO

Masatsune Okajima (55 yo)

5.2yrs

Tenure

JP¥177,557,000

Compensation

Mr. Masatsune Okajima serves as the Chief Executive Officer at StemRIM since October 2023. He has been the President at StemRIM since March 2019 and its Representative Director and served as its Chief Oper...


Leadership Team

NamePositionTenureCompensationOwnership
Kensuke Tomita
Executive Chairman10.8yrsJP¥124.13m8.15%
¥ 2.4b
Masatsune Okajima
President5.2yrsJP¥177.56m0.41%
¥ 121.0m
Katsuto Tamai
Chief Scientific Officerless than a yearno data15.78%
¥ 4.6b
Takehiko Yamazaki
Head of Drug Discovery5.3yrsno data3.98%
¥ 1.2b

2.9yrs

Average Tenure

59yo

Average Age

Experienced Management: 4599's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kensuke Tomita
Executive Chairman10.8yrsJP¥124.13m8.15%
¥ 2.4b
Masatsune Okajima
President5.2yrsJP¥177.56m0.41%
¥ 121.0m
Katsuto Tamai
Chief Scientific Officer1.6yrsno data15.78%
¥ 4.6b
Noriko Sawai
Independent Outside Director4.6yrsno data0.0049%
¥ 1.4m
Yoji Kudo
Full-Time External Audit & Supervisory Board Member6.6yrsno data0.083%
¥ 24.2m
Akihiro Mizukami
External Audit & Supervisory Board Member4.6yrsno data0.092%
¥ 26.8m
Yoichiro Shimada
External Audit & Supervisory Board Member4.6yrsno data0.019%
¥ 5.5m
Tadahiro Nagai
Independent Outside Director3.6yrsno data0.0049%
¥ 1.4m

4.6yrs

Average Tenure

65yo

Average Age

Experienced Board: 4599's board of directors are considered experienced (4.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.